Current Projects

                       asian lab tech blue pms2945  green peti dish  lab2 pink pms213  doctors conf green pms374  conf overhead purple pms2593

DISEASE AREA INSTITUTION LEAD RESEARCHER PROJECT NAME TYPE OTHER STATUS
Diabetes Massachusetts General Hospital Dr. Faustman Repurposing a Vaccine for Type I Diabetes Drug Adult In Process
Diabetic Ophthalmology Northwestern University Dr. Basti Treating Cataracts in Diabetic Patients Using a Surgical Device Device Adult Started 2018
GI Boston Children's Hospital Dr. Kahn

Fecal Microbiota Transplantation Patient Registry for Pediatric C-diff

Other Pediatric In Process
Neuro  Medical College of Wisconsin Dr. Alvarez Repurposing an Antipsychotic Drug as Treatment for Pediatric Delirium  Drug Pediatric Started 2018
Neuro  Cincinnati Children's Hospital Medical Center  Dr. Wink Repurposing a Generic Drug in Autism Spectrum Disorder  Drug  Pediatric   In Process
Neuro  Georgetown University  Dr. Anderson Using a Cancer Drug in Huntington's Disease  Drug  Adult  Started 2018 
Neuro University of Pennsylvania Medicine Dr. Oathes  Using Imaging Techniques to Guide Targeted Brain Stimulation in the Treatment of Depression and Post-Traumatic Stress Disorder  Device  Adult   In Process
Neuro University of Toronto Dr. Lanctôt  A New Opportunity to Treat Behavioral Problems in Alzheimer's Patients  Drug  Adult  In Process 
Oncology  Massachusetts General Hospital/Harvard Medical School, VUmc Cancer Center Amsterdam Dr. Tannous, Dr. Arrillaga-Romany, Dr. Kouwenhoven A Novel Combination of Generic Chemotherapy Drugs to Treat Brain Cancer Drug Adult Started 2018
Oncology Johns Hopkins Medicine Dr. Riggins  A Phase I Trial for Recurrent Pediatric Brain Cancers Using a Repurposed Generic Drug  Drug Pediatric Expanded 2017
Oncology The Hospital for Sick Children Dr. Suwwan  Low-Level Laser Therapy to Address Treatment Side Effects in Pediatric Cancer Patients Device  Pediatric  Started 2018
Oncology Ulm University Dr. Halatsch Combining Nine Repurposed Drugs with a Current Chemotherapy Treatment in Adult Brain Cancer  Drug  Adult In Process 
Oncology University of Chicago Dr. Patel Innovations in Combination Therapies for Non-Small Cell Lung Cancer  Drug  Adult In Process 
Oncology University of Michigan Dr. Swiecicki  Repurposing Old Drugs as New Therapies for Metastatic Thyroid Cancer* Drug   Adult Started 2018 
Oncology/Rare University of Michigan Dr. Pettit Using a Skin Cancer Drug to Improve Current Treatment in a Rare Blood Cancer Drug Adult Pending 2018
Ophthalmic University of Pennsylvania Medicine Dr. Kim  Repurposing a Nutraceutical to Treat a Type of Age-Related Macular Degeneration Nutraceutical  Adult In Process 
Ophthalmic/Rare University of Michigan Dr. Zacks Testing a Generic Malaria Drug in a Rare Ophthalmic Condition  Drug Adult Started 2018
Rare  Children's Hospital of Philadelphia, The Hospital for Sick Children  Dr. Levine,
Dr. Sochett
Repurposing an Antibiotic to Treat a Defect in Vitamin D Metabolism  Drug  Pediatric  In Process 
 Rare  Children's National Health System, University of Illinois at Chicago Dr. Nadler, Dr. Holterman Using a Cancer Drug to Treat a Rare Pediatric Liver Disease  Drug Pediatric Started 2018
Rare   The Hospital for Sick Children, National Institutes of Health Dr. Dowling,Dr. Bönnemann TAM4MTM: Tamoxifen Therapy for Myotubular Myopathy Drug  Pediatric In Process 
Rare University of Illinois at Chicago Dr. Havelka, Dr. Eton Saving Limbs from Chronic Ischemia: Helping Nature Do Its Magic Combo  Adult  In Process 
Traumatic Limb Injury The Pennsylvania State University and the Milton S. Hershey Medical Center Dr. Elfar Repurposing a Multiple Sclerosis Drug in Severe Limb Trauma* Diagnostic Adult Started 2018

 

*CureAccelerator Live! winner

 

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*

*required

If the link above doesn't work, please email susan@cureswithinreach.org with your Full Name and Email Address to sign up!

 

Cures Within Reach

info@cureswithinreach.org

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.

 

Monday the 21st. Copyright 2018 Cures Within Reach.